102 related articles for article (PubMed ID: 7028777)
1. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
Bansal SA; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
4. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
[TBL] [Abstract][Full Text] [Related]
5. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
[TBL] [Abstract][Full Text] [Related]
6. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
Miell JP; Corder R; Pralong FP; Gaillard RC
J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
[TBL] [Abstract][Full Text] [Related]
7. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
Bercu BB; Root AW; Shulman DI
J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
[TBL] [Abstract][Full Text] [Related]
8. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic modulation of meal-stimulated and circadian secretion of pancreatic polypeptide in man.
Stern N; Sowers JR; Taylor IL; Golub M
J Clin Endocrinol Metab; 1983 Feb; 56(2):300-4. PubMed ID: 6822639
[TBL] [Abstract][Full Text] [Related]
10. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic mechanisms and luteinizing hormone (LH) secretion. II. Differential effects of dopamine and bromocriptine on LH release in normal women.
Martin WH; Rogol AD; Kaiser DL; Thorner MO
J Clin Endocrinol Metab; 1981 Apr; 52(4):650-6. PubMed ID: 7204538
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
14. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
Huseman CA
J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
[TBL] [Abstract][Full Text] [Related]
15. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
Tortonese DJ
Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
[TBL] [Abstract][Full Text] [Related]
16. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
[TBL] [Abstract][Full Text] [Related]
17. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Apr; 62(4):783-4. PubMed ID: 3512593
[TBL] [Abstract][Full Text] [Related]
18. [Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture].
Deng J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):330-4. PubMed ID: 1966332
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
20. Different effects of metoclopramide and domperidone on GH release in type I male diabetics.
Volpi R; Coiro V; Castelli A; Cappagli M; Muzzetto P; Sciarra A; Chiodera P
Horm Metab Res; 1984 Dec; 16 Suppl 1():131-3. PubMed ID: 6532934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
